The Latest Breaking News from JJ.

Johnson & Johnson snagged Shockwave Medical in a $13.1 billion cardiovascular intervention deal that sent Shockwave stock rising Friday.

Dividend Kings are companies with a long history of paying and increasing shareholder dividends, which signals strong financial health for investors looking to build a steady stream of passive income.

Cancer-focused biotech companies Ambrx and Harpoon snapped up a pair of takeover deals. AMAM stock and HARP stock soared.

Scientists have offered a new explanation for why COVID-19 vaccines that contained adenoviruses carried a rare-but-serious risk of blood clotting.

The exit of a Johnson & Johnson exec raises an age-old question about women's ambition.

J&J is facing tens of thousands of cases involving its talc-based powder.

Joe Wolk, with J&J for over 25 years, talks about his path and the company's focus on innovation.

In a series of moves experts say signal a shift in how developing countries deal with pharmaceuticals, South Africa, Colombia and others have recently adopted a more combative approach towards drugmakers, pushing back on policies that deny treatment to millions of people with tuberculosis and HIV

The legendary value investor slashed two consistent dividend-paying stocks from Berkshire Hathaway's portfolio in the latest quarter, according to regulatory filings.